
<table style="text-align:center"><caption><strong>Newey-West Adjusted Linear Models of Market Authorizations for New Orphan Drugs</strong></caption>
<tr><td colspan="6" style="border-bottom: 1px solid black"></td></tr><tr><td style="text-align:left"></td><td colspan="5"><em>Dependent variable:</em></td></tr>
<tr><td></td><td colspan="5" style="border-bottom: 1px solid black"></td></tr>
<tr><td style="text-align:left"></td><td colspan="5">Annual Number of Market Authorizations for New Orphan Drugs</td></tr>
<tr><td style="text-align:left"></td><td>Model 1</td><td>Model 2</td><td>Model 3</td><td>Model 4</td><td>Model 5</td></tr>
<tr><td colspan="6" style="border-bottom: 1px solid black"></td></tr><tr><td style="text-align:left">US (β<sup>̂</sup><sub>1</sub>)</td><td>15.556<sup>***</sup></td><td>3.534</td><td>3.327</td><td>-4.977</td><td>2.887</td></tr>
<tr><td style="text-align:left"></td><td>(3.229)</td><td>(4.316)</td><td>(2.407)</td><td>(4.042)</td><td>(6.422)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Years After 2004 (β<sup>̂</sup><sub>2</sub>)</td><td>1.358<sup>***</sup></td><td>0.311</td><td>0.654<sup>***</sup></td><td></td><td>0.318</td></tr>
<tr><td style="text-align:left"></td><td>(0.133)</td><td>(0.343)</td><td>(0.144)</td><td></td><td>(0.555)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Annual Domestic R&D Spending (Billions USD) (β<sup>̂</sup><sub>3</sub>)</td><td></td><td>0.564<sup>***</sup></td><td></td><td>0.517<sup>***</sup></td><td>0.280</td></tr>
<tr><td style="text-align:left"></td><td></td><td>(0.152)</td><td></td><td>(0.123)</td><td>(0.451)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Annual GDP Growth Rate Per Capita (β<sup>̂</sup><sub>4</sub>)</td><td></td><td>0.087</td><td>0.086</td><td>0.024</td><td>0.070</td></tr>
<tr><td style="text-align:left"></td><td></td><td>(0.161)</td><td>(0.128)</td><td>(0.133)</td><td>(0.135)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Years After 2004:US (β<sup>̂</sup><sub>5</sub>)</td><td></td><td></td><td>1.438<sup>***</sup></td><td></td><td>1.288<sup>*</sup></td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td>(0.248)</td><td></td><td>(0.721)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Annual Domestic R&D Spending (Billions USD):US (β<sup>̂</sup><sub>6</sub>)</td><td></td><td></td><td></td><td>0.206<sup>**</sup></td><td>-0.092</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td>(0.100)</td><td>(0.449)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Intercept (β<sup>̂</sup><sub>0</sub>)</td><td>-0.877</td><td>-6.351<sup>***</sup></td><td>4.831<sup>***</sup></td><td>-2.308</td><td>0.752</td></tr>
<tr><td style="text-align:left"></td><td>(2.559)</td><td>(1.760)</td><td>(1.440)</td><td>(3.268)</td><td>(7.162)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td colspan="6" style="border-bottom: 1px solid black"></td></tr><tr><td style="text-align:left">AIC</td><td>241</td><td>234</td><td>228</td><td>234</td><td>231</td></tr>
<tr><td style="text-align:left">RMSE</td><td>6.17</td><td>5.27</td><td>4.83</td><td>5.26</td><td>4.76</td></tr>
<tr><td style="text-align:left">Adj R<sup>2</sup></td><td>0.73</td><td>0.79</td><td>0.82</td><td>0.79</td><td>0.82</td></tr>
<tr><td style="text-align:left">F Statistic</td><td>47.69</td><td>33.63</td><td>41.5</td><td>33.79</td><td>26.75</td></tr>
<tr><td style="text-align:left">p-value</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td></tr>
<tr><td colspan="6" style="border-bottom: 1px solid black"></td></tr><tr><td style="text-align:left"><em>Note:</em></td><td colspan="5" style="text-align:right"><sup>*</sup>p<0.1; <sup>**</sup>p<0.05; <sup>***</sup>p<0.01</td></tr>
</table>
